BioVaxys Technology Corp. Company Profile, Contacts & Intelligence

Biotechnology Research146 Thirtieth Street Canada5 employeesFounded 2020
2 contacts with email or phone data2 with email data
View verified contacts Compare competitors
Employees
5
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 3 visible contacts
Departments
1
Mapped contact coverage

BioVaxys Technology Corp. Overview

BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies based on our DPX™ immune-educating delivery technology platform and our HapTenix© neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase IIb clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using our proprietary HapTenix© neoantigen tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. BioVaxys is capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens.

Headquarters
146 Thirtieth Street Canada
Website
biovaxys.com
Industry
Biotechnology Research
Founded
2020
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Oncology Biotechnology Melanoma Ovarian Cancer Cancer Vaccines Immunotherapeutics Cancer Vaccine virology Personalized Immunotherapy lipid delivery drug delivery

BioVaxys Technology Corp. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
Executive
1

BioVaxys Technology Corp. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

R
Rajkannan Rajagopalan
Nanoparticles Formulation
E
A
Anthony Dutton
E
D
David Berd
Chief Medical Officer at Biovaxys

BioVaxys Technology Corp. Workforce Composition

Seniority breakdown across 3 visible profiles.

Executive
2
Individual contributor
1

Compare Similar Companies to BioVaxys Technology Corp.

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
AOA Dx Biotechnology Research 54 View company
Accession Therapeutics Limited Biotechnology 45 View company
PineTree Therapeutics Inc Biotechnology 32 View company
Rocky Health Medical Practices 27 View company
Incyclix Bio Biotechnology 10 View company
Singula Bio Ltd. Biotechnology Research 8 View company
Lassogen, Inc. Biotechnology Research 5 View company
UPyTher Biotechnology Research 5 View company
Duo Oncology Pharmaceutical Manufacturing 4 View company
Omideon Limited Biotechnology Research 2 View company